DNA methylation profiling is intended to provide supplementary information for diagnosis and should be interpreted by qualified pathologists. These tests have not been cleared or approved by the US Food and Drug Administration (FDA). The FDA has determined that such clearance or approval is not necessary. Performance characteristics of the test were validated by the Laboratory of Pathology, CCR, NCI in a manner consistent with CLIA requirements. Testing, data analysis, and interpretation is performed per developer recommendations. This laboratory is certified under the Clinical Laboratory Improvement Amendments of 1988 (CLIA-88) as qualified to perform high complexity clinical laboratory testing.
